# Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability

> **NCT02603822** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 25 (actual)

## Conditions studied

- Impaired Small Intestinal Permeability

## Interventions

- **DIETARY_SUPPLEMENT:** 12C mannitol
- **DRUG:** Indomethacin
- **DIETARY_SUPPLEMENT:** 13C mannitol
- **DIETARY_SUPPLEMENT:** Lactulose

## Key facts

- **NCT ID:** NCT02603822
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2018-07-17
- **Final completion:** 2018-07-17
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603822, "Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02603822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*